Articles with "fusion inhibitor" as a keyword



Photo from wikipedia

In situ depot formation of anti-HIV fusion-inhibitor peptide in recombinant protein polymer hydrogel.

Sign Up to like & get
recommendations!
Published in 2017 at "Acta biomaterialia"

DOI: 10.1016/j.actbio.2017.10.024

Abstract: Most peptide drugs have short half-lives, necessitating frequent injections that may induce skin sensitivity reactions; therefore, versatile prolonged-release delivery platforms are urgently needed. Here, we focused on an oxidatively and thermally responsive recombinant elastin-like polypeptide… read more here.

Keywords: peptide; depot; hydrogel; fusion inhibitor ... See more keywords
Photo by charlesdeluvio from unsplash

Design, Characterization, and Biopharmaceutical Behavior of Nanoparticles Loaded with an HIV-1 Fusion Inhibitor Peptide.

Sign Up to like & get
recommendations!
Published in 2018 at "Molecular pharmaceutics"

DOI: 10.1021/acs.molpharmaceut.8b00609

Abstract: New therapeutic alternatives to fight against the spread of HIV-1 are based on peptides designed to inhibit the early steps of HIV-1 fusion in target cells. However, drawbacks, such as bioavailability, short half-life, rapid clearance,… read more here.

Keywords: inhibitor peptide; hiv fusion; fusion inhibitor; fusion ... See more keywords
Photo by charlesdeluvio from unsplash

A Protein-Based, Long-Acting HIV-1 Fusion Inhibitor with an Improved Pharmacokinetic Profile

Sign Up to like & get
recommendations!
Published in 2022 at "Pharmaceuticals"

DOI: 10.3390/ph15040424

Abstract: Recently, a series of highly effective peptide- or protein-based HIV fusion inhibitors have been identified. However, due to their short half-life, their clinical application is limited. Therefore, the development of long-acting HIV fusion inhibitors is… read more here.

Keywords: fusion inhibitor; fusion; hiv fusion; protein based ... See more keywords
Photo from wikipedia

A Modified Fibronectin Type III Domain-Conjugated, Long-Acting Pan-Coronavirus Fusion Inhibitor with Extended Half-Life

Sign Up to like & get
recommendations!
Published in 2022 at "Viruses"

DOI: 10.3390/v14040655

Abstract: The coronavirus disease 2019 (COVID-19) pandemic caused by infection of SARS-CoV-2 and its variants has posed serious threats to global public health, thus calling for the development of potent and broad-spectrum antivirals. We previously designed… read more here.

Keywords: half life; coronavirus; fusion inhibitor; pan ... See more keywords